OraSure Technologies Inc (OSUR)
4.03
-0.05
(-1.23%)
USD |
NASDAQ |
Jul 03, 16:00
OraSure Technologies Research and Development Expense (Annual): 33.73M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.73M |
| December 31, 2022 | 36.24M |
| December 31, 2021 | 34.17M |
| December 31, 2020 | 31.03M |
| December 31, 2019 | 19.63M |
| December 31, 2018 | 16.25M |
| December 31, 2017 | 13.36M |
| December 31, 2016 | 9.754M |
| December 31, 2015 | 11.65M |
| December 31, 2014 | 12.06M |
| December 31, 2013 | 10.93M |
| December 31, 2012 | 12.44M |
| December 31, 2011 | 18.41M |
| December 31, 2010 | 13.19M |
| December 31, 2009 | 13.37M |
| Date | Value |
|---|---|
| December 31, 2008 | 20.26M |
| December 31, 2007 | 14.14M |
| December 31, 2006 | 8.648M |
| December 31, 2005 | 5.269M |
| December 31, 2004 | 6.062M |
| December 31, 2003 | 8.000M |
| December 31, 2002 | 8.274M |
| December 31, 2001 | 9.389M |
| December 31, 2000 | 10.40M |
| September 30, 1999 | 4.00M |
| September 30, 1998 | 2.90M |
| September 30, 1997 | 4.20M |
| September 30, 1996 | |
| September 30, 1995 | |
| September 30, 1994 | 6.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
19.63M
Minimum
2019
36.24M
Maximum
2022
30.96M
Average
33.73M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Integra Lifesciences Holdings Corp | 104.19M |
| Insulet Corp | 205.00M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |